Eli Lilly Executive Compensation Details Revealed
Ticker: LLY · Form: DEF 14A · Filed: Mar 21, 2025 · CIK: 59478
| Field | Detail |
|---|---|
| Company | Eli Lilly & Co (LLY) |
| Form Type | DEF 14A |
| Filed Date | Mar 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, DEF-14A, annual-filing
Related Tickers: LLY
TL;DR
LLY's 2025 DEF 14A shows exec pay details for FY24, including pension and equity awards.
AI Summary
Eli Lilly and Company (LLY) filed its DEF 14A on March 21, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on aggregated changes in pension values and retirement benefits, as well as equity awards granted and outstanding. Specific dollar amounts and dates related to these compensation elements are provided for the fiscal years 2024, 2023, and 2022.
Why It Matters
This filing provides transparency into how Eli Lilly compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing disclosing executive compensation and does not present new material risks.
Key Numbers
- 2024 — Fiscal Year End (Primary year for compensation data presented)
- 2023 — Fiscal Year End (Comparative year for compensation data)
- 2022 — Fiscal Year End (Comparative year for compensation data)
Key Players & Entities
- Eli Lilly & Co (company) — Filer of the DEF 14A
- 0000059478 (company) — Central Index Key for Eli Lilly & Co
- 20250321 (date) — Filing date of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for compensation data
- 2023-12-31 (date) — Prior fiscal year end for compensation data
- 2022-12-31 (date) — Prior fiscal year end for compensation data
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose of this DEF 14A filing is to provide detailed information regarding Eli Lilly and Company's executive compensation for the fiscal year ending December 31, 2024.
When was this DEF 14A filed with the SEC?
This DEF 14A filing was filed with the SEC on March 21, 2025.
What specific compensation elements are detailed in the filing?
The filing details elements such as aggregated changes in pension values, retirement benefits, and equity awards granted and outstanding for the covered fiscal years.
For which fiscal years does the filing provide compensation data?
The filing provides compensation data for the fiscal years ending December 31, 2024, 2023, and 2022.
What is Eli Lilly and Company's Central Index Key (CIK)?
Eli Lilly and Company's Central Index Key (CIK) is 0000059478.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 21, 2025 regarding ELI LILLY & Co (LLY).